Daiichi-Sankyo Becomes Newest IFPMA Member Company The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to welcome Daiichi-Sankyo Company Limited as its newest member company. IFPMA Director General Alicia Greenidge said: "We are very delighted to welcome Daiichi-Sankyo to IFPMA. This development will further enhance IFPMA's membership and Daiichi-Sankyo's vision as a truly global pharmaceutical innovator.
Source: www.medicalnewstoday.comPeople With Mental Illnesses Wait Longer In Emergency Departments As Hospitals Close Psychiatric Units, According To Survey Nearly 80% of hospitals say mentally ill patients who need to be hospitalized sometimes must wait four hours or longer to be admitted because of a shortage of psychiatric beds and mental
health staff, according to a survey by the American College of Emergency Physicians, USA Today reports.
Source: www.medicalnewstoday.comOlder Men With Low Testosterone Benefit From Testosterone Replacement In older men with low testosterone levels, testosterone replacement therapy improves their risk factors for cardiovascular disease and diabetes, according to two new studies. The results were presented at The Endocrine Society's 90th Annual Meeting in San Francisco.Testosterone deficiency becomes more common with age, occurring in 18 percent of 70-year-olds, said a coauthor of both studies, Farid Saad, PhD, of Berlin-headquartered Bayer Schering Pharma.
Source: www.medicalnewstoday.comDrug Makers Lobbying States To Restrict Use Of Lower-Cost Generic Alternatives Pharmaceutical companies, which "have been waging war against inexpensive generic
drugs for years at the national level," are now "taking their fights to the states, promoting proposals that would" bar pharmacists from automatically replacing
prescriptions for brand-name
drugs with generics, the Baltimore Sun reports.
Source: www.medicalnewstoday.comThomson Reuters Launches New Biomarkers Solution - First Comprehensive And Quality Assured Biomarker Solution Available To The Pharmaceutical Industry Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced the launch of BIOMARKERcenter, a unique comprehensive resource for biomarker intelligence. This new solution will be the first to provide the pharmaceutical industry with a framework for assessing the potential of a biomarker and to be alerted of any changes in their status.
Source: www.medicalnewstoday.comClaims Linking Health Problems And The Strength Of Cannabis May Be Exaggerated Claims that a large increase in the strength of cannabis over the last decade is driving the occurrence of mental
health and other problems for users are not borne out by a study of the worldwide literature, say researchers at the National Drug and Alcohol Research Centre (NDARC) and the National Drug Research Institute (NDRI), both from Australia.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 1:00 PM
